Poor bioavailability, unstable therapeutics, limited tissue penetration, and off-target toxicity continue to constrain antiviral R&D. Liposome-based delivery systems offer researchers a flexible route to overcome these barriers.   Developing an effective therapeutic is only part of the challenge in modern drug discovery. Researchers must also ensure that an active molecule reaches the...